Press Releases

05 Aug '21
Second quarter GAAP diluted EPS of $0.15 ; non-GAAP diluted EPS of $0.23 , up 35% year-over-year Generated $69 million of cash flow from continuing operations and $51 million of free cash flow in the second quarter Increasing 2021 outlook for Adjusted EBITDA and free cash flow CHICAGO --(BUSINESS
26 May '21
CHICAGO --(BUSINESS WIRE)--May 26, 2021-- Allscripts Healthcare Solutions announced today that its Board of Directors has approved a new share repurchase program under which Allscripts may purchase up to $350 million of its common stock. The new share repurchase program does not have a termination

Contact Investor Relations

Stephen Shulstein
Vice President, Investor Relations
Stephen.Shulstein@allscripts.com